Art of the Kill: UV inactivation for Rapid Response. Protein and PCR intact virus for next-gen vaccines, diagnostics, and biodefense.
RoLink Biotechnology has raised $750K in total funding. The most recent round was Grant. The last funding was announced in November 2023.
RoLink Biotechnology is headquartered in Pécs, Hungary.
Art of the Kill: UV inactivation for Rapid Response. Protein and PCR intact virus for next-gen vaccines, diagnostics, and biodefense.
RoLink Biotechnology is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RoLink Biotechnology — Funding & Investors." VCBacked, November 1, 2023, https://www.vcbacked.co/company/rolink-biotechnology. Accessed August 14, 2026.
VCBacked. (2023). RoLink Biotechnology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rolink-biotechnology
{{cite web |title=RoLink Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/rolink-biotechnology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated